Table 3.
Immunohistochemical expression of cell cycle and apoptotic regulatory protein antibodies
| Antibody Used | Number of Cases | % Positive |
|---|---|---|
| BAD | 19 | 82.6 |
| Mcl-1 | 8 | 34.8 |
| Bcl-2 | 6 | 26.1 |
| Bcl-x | 3 | 13.0 |
| Bak | 17 | 73.9 |
| Mdm-2 | 4 | 17.4 |
| Bax | 14 | 60.9 |
| p16 | 7 | 30.4 |
| p21 | 5 | 21.7 |
| p27 | 0 | 0 |
| p53 | 15 | 65.2 |
| Cyc-D1 | 0 | 0 |
| Ki-67 | 10 | 43.5 |
| PCNA | 11 | 47.8 |
The number of cases and their percentage of expression are listed with respect to the oncoproteins used in this study: Bad, Mcl-1, Bcl-2, Bcl-x, Bak, Mdm-2, Bax, p16, p21, p27, p53, Cyc-D1, Ki-67, PCNA.